Pouran Varvani Farahani
Nicosia, North Cyprus, Cyprus
NCT Number: NCT07684378
Human papillomavirus (HPV) is one of the most common sexually transmitted infections worldwide and is associated with several cancers. Adequate knowledge about HPV and vaccination remains limited among university students. This randomized controlled trial aims to evaluate the effectiveness of an artificial intelligence (AI) chatbot-based educational program in improving HPV knowledge among undergraduate nursing students at Cyprus International University. Participants will be randomly assigned to either an AI chatbot-based personalized education group or a control group receiving standard written educational materials. HPV knowledge will be assessed before and after the intervention using the validated HPV Knowledge Questionnaire. The findings will provide evidence regarding the effectiveness of AI-supported educational strategies for improving HPV-related knowledge among university students
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Nicosia, North Cyprus, Cyprus
Study Purpose
The purpose of this study was to evaluate the effectiveness of an AI chatbot-based educational program in improving Human Papillomavirus (HPV) knowledge among undergraduate nursing students.
Study Design
This study was designed as a parallel-group randomized controlled trial conducted among undergraduate nursing students at Cyprus International University, Northern Cyprus. Participants were randomly assigned to either the intervention group (AI chatbot-based personalized education) or the control group (standard written educational materials) using block randomization.
Sample Size
Based on a previous educational intervention study and the two-sample mean comparison formula, with a significance level of 0.05 and a statistical power of 80%, the required sample size was calculated as 30 participants per group. After allowing for a 10% dropout rate, a total of 68 participants were enrolled, with 34 participants allocated to each study group.
Data Collection Tools
Data were collected using:
A demographic questionnaire (age, gender, faculty, year of study, previous HPV education, source of HPV information, and HPV vaccination status).
The validated 29-item HPV Knowledge Questionnaire developed , assessing general HPV knowledge, HPV testing knowledge, and HPV vaccination knowledge.
Intervention
Participants were randomly assigned to one of two groups.
AI Chatbot Group:
Participants received personalized HPV education through an artificial intelligence (AI) chatbot. Educational content was tailored according to each participant's baseline HPV knowledge and included information on HPV transmission, risk factors, HPV-related diseases, vaccination, prevention strategies, and common misconceptions.
Control Group:
Participants received standard written educational materials covering the same HPV-related topics without chatbot interaction or personalized educational content.
Outcome Assessment
HPV knowledge was measured before and after the educational intervention using the validated HPV Knowledge Questionnaire.
Ethical Considerations
The study received approval from the Cyprus International University Ethics Review Board (Approval No. EKK25-26/15/08). The study was conducted in accordance with the Declaration of Helsinki, and written informed consent was obtained from all participants before enrollment.
Statistical Analysis
Data will be analyzed using SPSS version 26. Descriptive statistics, independent t-tests, paired t-tests, Chi-square tests, Fisher's exact tests, and non-parametric tests will be performed as appropriate. Statistical significance will be be set at a two-sided P value of less than 0.05.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants received personalized education through an artificial intelligence (AI) chatbot. Educational content was tailored according to each participant's baseline HPV knowledge and included information on HPV transmission, risk factors, HPV-related diseases, HPV vaccination, prevention strategies, and common misconceptions. The chatbot provided interactive, personalized educational support throughout the intervention
Participants received standard written educational materials covering HPV transmission, risk factors, HPV-related diseases, HPV vaccination, and prevention strategies. The educational materials were identical in content to the intervention group but were provided without personalization or AI chatbot interaction
Time frame: Baseline (before the educational intervention) and 1 month after completion of the educational intervention.
The primary outcome measure assesses changes in participants' knowledge of Human Papillomavirus (HPV) following the educational intervention. HPV knowledge is measured using the validated 29-item HPV Knowledge Questionnaire developed by Waller et al. (2013). The questionnaire evaluates three domains: general HPV knowledge, HPV testing knowledge, and HPV vaccination knowledge. Higher total scores indicate greater HPV-related knowledge
Near East University, Turkey
Other
Effect of an AI Chatbot-Based Educational Program on HPV Knowledge Among University Students
Acronym: AIHPV
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07087444
Adherence Interventions, Behavior
Buea, SWR, Cameroon
View Trial DetailsNCT07660705
Adherence Interventions, Anxiety
Elâzığ, Merkez, Turkey (Türkiye)
View Trial DetailsNCT07711301
Adherence Interventions, Behavior
Boston, Massachusetts, United States
View Trial DetailsNCT07521163
Adherence Interventions, Behavior
Van, Turkey (Türkiye)
View Trial Details